Makoto Nakajima Selected Research

Makoto Nakajima Research Topics

Disease

18	Stroke (Strokes) 07/2023 - 10/2002
10	Ischemic Stroke 03/2022 - 06/2013
5	Chronic Renal Insufficiency 01/2016 - 07/2012
4	Atrial Fibrillation 01/2022 - 04/2015
3	Infarction (Infarctions) 05/2023 - 10/2014
3	Hypertension (High Blood Pressure) 12/2022 - 12/2020
3	Infections 06/2022 - 06/2009
3	Transient Ischemic Attack 03/2022 - 06/2013
3	Hemorrhagic Stroke 03/2022 - 12/2019
3	Hematoma 09/2020 - 03/2008
3	Atrophy 01/2017 - 04/2013
3	Lacunar Stroke 05/2015 - 10/2014
3	Hemorrhage 04/2015 - 01/2013
3	Ischemia 07/2006 - 05/2005
2	Drowning 11/2023 - 10/2021
2	Cerebral Amyloid Angiopathy (Congophilic Angiopathy) 12/2022 - 01/2019
2	Cerebral Hemorrhage 03/2022 - 12/2019
2	Pulmonary Embolism 09/2021 - 01/2006
2	Neoplasms (Cancer) 09/2021 - 04/2013
2	Guillain-Barre Syndrome 07/2021 - 10/2019
2	Disease Progression 12/2019 - 01/2017
2	Thrombosis (Thrombus) 10/2018 - 01/2007
2	Embolic Stroke 05/2018 - 01/2007
2	Brain Neoplasms (Brain Tumor) 12/2017 - 04/2015
2	Hyperplasia 01/2017 - 01/2009
2	Sudden Death 12/2014 - 03/2014
2	Myocardial Ischemia (Ischemic Heart Diseases) 03/2006 - 05/2005
1	Hypothermia 11/2023
1	Seizures (Absence Seizure) 05/2023
1	Hereditary Nephritis (Alport Syndrome) 01/2023
1	Leukoencephalopathies 12/2022
1	Edema (Dropsy) 12/2022
1	T-Cell Lymphoma (Lymphoma, T Cell) 06/2022
1	Dyslipidemias (Dyslipidemia) 03/2022
1	Diabetes Mellitus 03/2022
1	CADASIL 01/2022
1	Diabetes Complications 10/2021
1	Bone Fractures (Bone Fracture) 09/2021
1	Transthyretin-Related Hereditary Amyloidosis 01/2021
1	Amyloidosis 01/2021
1	Virus Diseases (Viral Diseases) 12/2020
1	COVID-19 12/2020
1	Hyperalgesia 09/2020
1	Quadriplegia (Spastic Quadriplegia) 09/2020
1	Burns 06/2020
1	Brain Diseases (Brain Disorder) 03/2020
1	Venous Thrombosis (Deep-Vein Thrombosis) 12/2019

Drug/Important Bio-Agent (IBA)

9	AnticoagulantsIBA 03/2022 - 01/2007
3	fibrin fragment D (D-dimer)IBA 03/2022 - 12/2020
3	AntibodiesIBA 01/2022 - 04/2018
3	Proteins (Proteins, Gene)FDA Link 10/2021 - 07/2006
3	SteroidsIBA 09/2021 - 10/2019
3	Sulfates (Sulfates, Inorganic)IBA 02/2015 - 04/2013
2	Hemoglobins (Hemoglobin)IBA 05/2023 - 07/2018
2	Glucose (Dextrose)FDA LinkGeneric 05/2023 - 07/2006
2	Vitamin K FDA Link 03/2022 - 01/2022
2	Natriuretic PeptidesIBA 03/2022 - 03/2014
2	Intravenous Immunoglobulins (IVIG)FDA Link 07/2021 - 10/2019
2	Warfarin (Coumadin)FDA LinkGeneric 07/2021 - 12/2019
2	Prealbumin (Transthyretin)IBA 01/2021 - 01/2019
2	CytokinesIBA 10/2018 - 04/2013
2	Uremic ToxinsIBA 01/2016 - 09/2015
2	Furosemide (Lasix)FDA LinkGeneric 01/2010 - 01/2009
2	Oxygen (Dioxygen)IBA 07/2006 - 05/2005
1	Ethanol (Ethyl Alcohol)IBA 11/2023
1	Collagen Type IV (Type IV Collagen)IBA 01/2023
1	Amyloid (Amyloid Fibrils)IBA 12/2022
1	Apolipoproteins E (ApoE)IBA 12/2022
1	ApolipoproteinsIBA 12/2022
1	Antihypertensive Agents (Antihypertensives)IBA 12/2022
1	N(4)-oleylcytosine arabinosideIBA 03/2022
1	3-hydroxy-5-estrane-17-carbonitrile (ACN)IBA 01/2022
1	SugarsIBA 10/2021
1	Advanced Glycation End ProductsIBA 10/2021
1	arginyllysineIBA 10/2021
1	pyridineIBA 10/2021
1	Immunoglobulins (Immunoglobulin)IBA 09/2021
1	Fibrinolytic Agents (Antithrombotic Agents)IBA 07/2021
1	Indicators and Reagents (Reagents)IBA 02/2021
1	Troponin T (Troponin T1)IBA 01/2021
1	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2021
1	Growth Differentiation Factor 15IBA 01/2021
1	GadoliniumIBA 01/2021
1	Tissue Plasminogen Activator (Alteplase)FDA Link 11/2020
1	Iodide Peroxidase (Deiodinase)IBA 03/2020
1	Methylprednisolone FDA LinkGeneric 03/2020
1	anti-thyroglobulinIBA 03/2020

Therapy/Procedure

14	Therapeutics 06/2022 - 11/2008
3	Drug Therapy (Chemotherapy) 06/2022 - 04/2013
3	Renal Dialysis (Hemodialysis) 01/2016 - 07/2012
3	Secondary Prevention 05/2015 - 06/2013
2	Thrombectomy 01/2021 - 12/2020
2	Cranial Irradiation 12/2017 - 01/2015
2	Self Administration (Administration, Self) 03/2014 - 01/2009
1	Early Ambulation 07/2023
1	Injections 10/2021
1	Thrombolytic Therapy 11/2020
1	Laminectomy 09/2020
1	Transcutaneous Electric Nerve Stimulation (TENS) 06/2020
1	Immunotherapy 03/2020